University of Alberta Hospital - General Systems Intensive Care Unit
University of Alberta Hospital - General Systems Intensive Care Unit
Site Lead Investigator: Dr. O Rewa
Theme | Project Name | Investigator |
Perioperative Medicine | Lessening Organ Dysfunction with Vitamin C (LOVITT) | Dr. O Rewa |
Perioperative Medicine | REVISE | Dr. O Rewa |
Infectious Diseases | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Randomized Controlled Trial (BALANCE) | Dr. W Sligl |
CC Nephrology | Continuous Renal Replacement Therapy Protocol: CRRTnet A Multicenter Data Registry for Outcomes for Continuous Renal Replacement Therapy | |
Infectious Diseases | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community Acquired Pneumonia (REMAP-CAP) | Dr. W Sligl |
Frailty | Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST) | Dr. O Rewa |
CC Cardiology | Myocardial Ischemia and Transfusion (MINT) | Dr. J Senaratne |
COVID-19 Studies | ||
Infectious Diseases | Short Period Incidence Study of Severe Acute Respiratory Infection (SPRINT-SARI) | Dr. O Rewa |
Infectious Diseases | The ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease (ECMO-CARD) | Dr. G Singh |
Infectious Diseases | Immune Response & Immune Function | Dr. W Sligl |
Infectious Diseases | A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients (CATCO) | Dr. N Lee |